Investigating the New Coronavirus with Karla Satchell, PhD, Part 2
This is an update to the Jan. 28, 2020 episode about Northwestern microbiologist Karla Satchell's effort to lead an investigation into the structure biology of the components of COVID-19. The goal is to ultimately understand how to stop the virus from replicating in human cells through a medication or vaccine.
"This is the third major epidemic of a coronavirus in only 20 years. So, we should think that something unexpected could happen again in seven to eight years. I think that we do need to be thinking about coronaviruses and transmission to humans as something that's going to keep happening and we need drugs available that we can immediately bring into that space."
- Director of the Center for Structural Genomics of Infectious Diseases
- Professor of Microbiology-Immunology
- Member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Member of the Northwestern University Clinical and Translational Sciences Institute
In January 2020, when COVID-19 was emerging worldwide, Karla Satchell, PhD, and members of the Center for Structural Genomics of Infectious Diseases at Northwestern were waiting for synthetic DNA of the virus to help them model its structure biology. The center, which is funded by the National Institute for Allergy and Infectious Diseases, has made much progress since that time. In just over two months, their group has solved and deposited structures of seven different proteins in a worldwide effort to develop a medication or vaccine for the virus.
- Read about the new drug target found for COVID-19 in mid-March by Satchell’s group.
- Listen to part one of the conversation with Satchell, recorded January 2020.
- Find out more about the Center for Structural Genomics of Infectious Diseases.
Subscribe to Feinberg School of Medicine podcasts here:
Continuing Medical Education Credit
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
Academic/Research, Multiple specialties
At the conclusion of this activity, participants will be able to:
- Identify the research interests and initiatives of Feinberg faculty.
- Discuss new updates in clinical and translational research.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this Enduring Material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Karla Satchell, PhD, disclosed a financial relationship with Situ Biosciences, LLC. Course director, Robert Rosa, MD, has nothing to disclose. Planning committee member, Erin Spain, has nothing to disclose. Feinberg School of Medicine's CME Leadership and Staff have nothing to disclose: Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Manager of CME, Jennifer Banys, Senior Program Administrator, Allison McCollum, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.